Results 191 to 200 of about 11,865,109 (300)

Implementation of male-specific motivational interviewing in Malawi: an assessment of intervention fidelity and barriers to scale-up. [PDF]

BMJ Glob Health
Holland KN, Hubbard J, Mphande M, Robson I, Phiri K, Onoya D, Chikuse E, Dovel K, Choko AT.   +8 more
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

How is health equity considered in scale-up guidance? A scoping review of process models for scaling public health innovations. [PDF]

Health Promot Int
Marshall S, Frolov E, de Carvalho Corôa R, Koorts H, Milat A, Lee K.   +5 more
europepmc   +1 more source

Proteasomal degradation of intracellularly expressed Amblyomin‐X limits suicide gene therapy potential in melanoma cells

FEBS Open Bio, EarlyView.
This study explores the feasibility of expressing the antitumoral protein Amblyomin‐X through a suicide gene therapy approach and investigates its intracellular fate after gene delivery. Although the gene is efficiently expressed, melanoma cells rapidly degrade the Amblyomin‐X protein via proteasome activity.
Victor Dal Posolo Cinel, Carlos DeOcesano Pereira, Aline Ramos Maia Lobba, Melissa Regina Fessel, Ana Marisa Chudzinski‐Tavassi   +4 more
wiley   +1 more source

Commercial Translation of Electrochemical Biosensors: Supply Chain Strategy, Scale-Up Manufacturing, and Regulatory-Quality Considerations. [PDF]

Biosensors (Basel)
Zhou G, Liu H.
europepmc   +1 more source

Rapid screening of staphylokinase protein variants using an unpurified cell‐free expression system

FEBS Open Bio, EarlyView.
An unpurified cell‐free protein synthesis (CFPS) platform enables rapid functional screening of staphylokinase variants. Direct plasminogen‐activation assays performed in microplate format provide real‐time activity readouts, allowing rapid identification and ranking of variants with improved or reduced fibrinolytic activity without protein ...
Maria Tomková, Veronika Hovanová, Jiri Damborsky, Erik Sedlák   +3 more
wiley   +1 more source

A theoretically designed scale-up intervention increases adoption of an effective school nutrition program 'SWAP IT': outcomes of a randomised trial. [PDF]

Int J Behav Nutr Phys Act
Sutherland R, Herdegen D, Jones J, Barnes C, Nathan N, Robertson K, Rayward A, Bauman A, McFadyen T, Milat A, Morgan P, Reeves P, Oldmeadow C, Yoong S, Cobcroft M, Chiu S, Wiggers J, Wolfenden L.   +17 more
europepmc   +1 more source

Scaling up diversity to scale up nutrition

, 2019
Schlecht, Martin Thomas, Berndt, Sascha, Greber, Josefine, Marinko, Jan, Archibong, Ukeme Okon, Schmidt, Anja, Speckhahn, Carolin, Weinsheimer, Hanna   +7 more
openaire   +1 more source

Combined 5‐aminolevulinic acid and ferric ammonium citrate treatment promotes hair follicle growth by activating dermal papilla cells

FEBS Open Bio, EarlyView.
5‐Aminolevulinic acid combined with ferric ammonium citrate (5‐ALA/FAC) stimulates dermal papilla cell activity and promotes hair follicle growth. The treatment enhances ERK and AKT signaling, increases hair‐inductive gene expression, and restores dermal papilla function suppressed by dihydrotestosterone and oxidative stress, resulting in enhanced hair
Han‐Wook Ryu, Eok‐Soo Oh, Sewoon Kim
wiley   +1 more source

Successes and setbacks in dual HIV/syphilis test scale-up strategies: Lessons learned for testing integration in an era of declining resources. [PDF]

Health Policy Open
Monroe-Wise A, Maman D, Edun O, Storey A, Lubega M, Carmone A, Mungai J, Walia A, Bajis S, Sistla J, Konstantinova A, Efronson E, Barr-DiChiara M, Chetty A, Thuy Nguyen VT, Owiredu MN, Johnson CC.   +16 more
europepmc   +1 more source